Sandoz launches generic psoriasis treatment
PRINCETON, N.J. — Sandoz has launched a generic version of a topical medication used to treat psoriasis, the company said.
Sandoz, the generics arm of Swiss drug maker Novartis, announced the launch of calcipotriene cream in the 0.005% strength, calling it the first generic version of Leo Pharma's Dovonex.
Dovonex had sales of about $118.8 million during the 12-month period ended in May, according to IMS Health.
Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.